Home LiteratureArticle Details
PMID: 10951568 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.

Oncogene ·Vol. 19 ·No. 32 ·2000-07-27 ·Pages 3623-31

Go C, He W, Zhong L, Li P, Huang J, Brinkley BR, Wang XJ

Abstract

Mutations in the transforming growth factor beta type II receptor (TGFbetaRII) have been found in various malignant tumors, suggesting that loss of TGFbeta signaling plays a causal role in late-stage cancer development. To test whether loss of TGFbetaRII is involved in early-stage carcinogenesis, we have generated transgenic mice expressing a dominant negative TGFbetaRII (deltabetaRII) in the epidermis. These mice exhibited an increased susceptibility to chemical carcinogenesis protocols at both early and late stages. In the current study, parameters for cell cycle progression and chromosome instability were analysed in deltabetaRII tumors. DeltabetaRII papillomas showed an increased S phase in flow cytometry. Bromodeoxyuridine (BrdU) labeling and mitotic indices in deltabetaRII papillomas also showed a threefold increase compared to papillomas developing in non-transgenic mice. When papillomas further progressed to squamous cell carcinomas (SCC), both control and deltabetaRII SCC showed similar BrdU labeling indices and percentages of S phase cells. However, deltabetaRII SCC cells showed a sixfold increase in the G2/M population. Mitotic indices in deltabetaRII SCC also showed a threefold increase compared to non-transgenic SCC. Consistent with a perturbed cell cycle, deltabetaRII papillomas and SCC showed reduced expression of the TGFbeta target genes p15 (INK4b), p21 (WAF-1) and p27 (Kip1), inhibitors of cyclin-dependent kinases (cdks). However, most deltabetaRII papilloma cells exhibited normal centrosome numbers, and deltabetaRII SCC exhibited a similar extent of centrosome abnormalities compared to control SCC (35-40% cells). Most of deltabetaRII SCC exhibited diploid chromosome profiles. These data indicate that inactivation of TGFbetaRII accelerates skin tumorigenesis at early stages by the acceleration of loss of cell cycle control, but not by increased chromosome instability.

MeSH Terms
9,10-Dimethyl-1,2-benzanthracene/adverse effects,pharmacology Animals Bromodeoxyuridine/pharmacokinetics Carcinogens/adverse effects,pharmacology Carcinoma, Squamous Cell/chemically induced,pathology Carrier Proteins/genetics Cell Cycle Cell Cycle Proteins Cell Transformation, Neoplastic Centrosome Cyclin-Dependent Kinase Inhibitor p15 Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p27 Epidermal Cells Gene Expression Mice Mice, Transgenic Microtubule-Associated Proteins/genetics Mitosis Papilloma/chemically induced,pathology Protein Serine-Threonine Kinases Receptor, Transforming Growth Factor-beta Type II Receptors, Transforming Growth Factor beta/biosynthesis,genetics,physiology Tetradecanoylphorbol Acetate/adverse effects,pharmacology Time Factors Tumor Suppressor Proteins
Chemicals
Carcinogens Carrier Proteins Cdkn1b protein, mouse Cdkn2b protein, mouse Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p15 Cyclin-Dependent Kinase Inhibitor p16 Microtubule-Associated Proteins Receptors, Transforming Growth Factor beta Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 9,10-Dimethyl-1,2-benzanthracene Protein Serine-Threonine Kinases Receptor, Transforming Growth Factor-beta Type II Bromodeoxyuridine Tetradecanoylphorbol Acetate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Go C
Department of Otolaryngology, Baylor College of Medicine, Houston, Texas 77030, USA.
He W
Zhong L
Li P
Huang J
Brinkley B R
Wang X J
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
2000-07-27
Pages
3623-31
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NCI NIH HHS · CA64255 · United States
NCI NIH HHS · CA79998 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com